Review: taking Metoprolol tartrate and Midol together


Summary

Drug interactions are reported among people who take Metoprolol tartrate and Midol together. This review analyzes the effectiveness and drug interactions between Metoprolol tartrate and Midol. It is created by eHealthMe based on reports of 1,529 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Metoprolol tartrate and Midol >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 38,992 users)

Midol

Midol has active ingredients of ibuprofen. It is often used in dysmenorrhoea. (latest outcomes from Midol 2,267 users)

On Jul, 23, 2016

1,529 people who take Metoprolol Tartrate, Midol are studied.


Number of reports submitted per year:

Metoprolol tartrate and Midol drug interactions.

Drug effectiveness over time:

Metoprolol Tartrate:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 62.0% - (5 of 8 people)
  • 6 - 12 months: 33.0% - (2 of 6 people)
  • 1 - 2 years: 9.0% - (1 of 11 people)
  • 2 - 5 years: 45.0% - (5 of 11 people)
  • 5 - 10 years: 100.0% - (16 of 16 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Midol:
  • < 1 month: 42.0% - (3 of 7 people)
  • 1 - 6 months: 0.0% - (0 of 4 people)
  • 6 - 12 months: 12.0% - (1 of 8 people)
  • 1 - 2 years: 16.0% - (1 of 6 people)
  • 2 - 5 years: 25.0% - (2 of 8 people)
  • 5 - 10 years: 27.0% - (3 of 11 people)
  • 10+ years: 25.0% - (1 of 4 people)
  • not specified: 0.0% - (0 of 2 people)

Drug effectiveness by gender:

Metoprolol Tartrate:
  • female: 62.0% - (22 of 35 people)
  • male: 50.0% - (11 of 22 people)
Midol:
  • female: 20.0% - (6 of 29 people)
  • male: 23.0% - (5 of 21 people)

Drug effectiveness by age:

Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 75.0% - (12 of 16 people)
  • 40-49: 57.0% - (8 of 14 people)
  • 50-59: 35.0% - (5 of 14 people)
  • 60+: 66.0% - (8 of 12 people)
Midol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 12.0% - (1 of 8 people)
  • 40-49: 26.0% - (4 of 15 people)
  • 50-59: 13.0% - (2 of 15 people)
  • 60+: 36.0% - (4 of 11 people)

Most common drug interactions over time *:

< 1 month:
  • dyspnoea
  • sepsis
  • death
  • pneumonia
  • anxiety
  • asthenia
  • renal failure acute
  • cerebral venous thrombosis
  • depression
  • hypersensitivity
1 - 6 months:
  • nausea
  • headache
  • cardiac arrest
  • cardiac failure congestive
  • confusional state
  • fluid retention
  • gastric ulcer
  • hyponatraemia
  • myocardial infarction
  • renal failure
6 - 12 months:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • back pain - low
  • blood test abnormal
  • decreased appetite
  • headache - migraine with aura
  • heartbeat sensations
  • hypothyroidic goitre
  • low blood pressure
  • nausea
  • neck, shoulder and arm syndrome
1 - 2 years:
  • headache - migraine with aura
  • weakness
  • intussusception
  • nausea
  • pulmonary embolism
  • back pain - low
  • blood test abnormal
  • decreased appetite
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • gastrooesophageal reflux disease
2 - 5 years:
  • chest pain
  • deep vein thrombosis
  • emotional distress
  • hypertension
  • pain
  • coronary artery disease
  • pulmonary embolism
  • acute myocardial infarction
  • diabetes mellitus
  • fear
5 - 10 years:
  • intussusception
  • depression
  • anxiety
  • back pain
  • dizziness
  • dyspnoea
  • pain
  • accessory spleen
  • anxiety aggravated
  • atrial fibrillation/flutter
10+ years:
  • agitation
  • angina pectoris
  • anxiety
  • cardiac disorder
  • cognitive deterioration
  • coordination abnormal
  • cystitis
  • decubitus ulcer
  • dehydration
  • delusions, mixed
not specified:
  • pain
  • anxiety
  • dyspnoea
  • nausea
  • chest pain
  • back pain
  • fatigue
  • hypertension
  • asthenia
  • injury

Most common drug interactions by gender *:

female:
  • pain
  • dyspnoea
  • nausea
  • anxiety
  • chest pain
  • hypertension
  • back pain
  • dizziness
  • depression
  • asthenia
male:
  • pain
  • anxiety
  • fatigue
  • nausea
  • injury
  • dyspnoea
  • back pain
  • chest pain
  • dehydration
  • renal failure

Most common drug interactions by age *:

2-9:
  • accidental drug intake by child
  • hypertension
10-19:
  • cardiogenic shock
  • suicide attempt
  • coma
  • metabolic acidosis
  • nausea
  • overdose
  • hyperglycaemia
  • pulmonary oedema
  • ventricular fibrillation
  • alanine aminotransferase increased
20-29:
  • pain
  • pulmonary embolism
  • completed suicide
  • injury
  • chest pain
  • anxiety
  • deep vein thrombosis
  • depression
  • headache
  • hydronephrosis
30-39:
  • dyspnoea
  • anxiety
  • pain
  • abdominal pain
  • pulmonary embolism
  • depression
  • intussusception
  • polydipsia
  • polyuria
  • weight increased
40-49:
  • pain
  • chest pain
  • nausea
  • fatigue
  • dyspnoea
  • anxiety
  • back pain
  • abdominal pain
  • vomiting
  • anaemia
50-59:
  • pain
  • anxiety
  • chest pain
  • nausea
  • dyspnoea
  • injury
  • hypoaesthesia
  • pain in jaw
  • renal failure
  • oedema peripheral
60+:
  • pain
  • dyspnoea
  • anxiety
  • nausea
  • asthenia
  • hypotension
  • hypertension
  • back pain
  • dehydration
  • renal failure

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol tartrate and Midol?

Can you answer these questions?

More questions for: Metoprolol tartrate, Midol

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Midol

On eHealthMe, Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Midol (ibuprofen) is often used to treat dysmenorrhoea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.